bpc 157 lyme You've probably seen everyone online talking about the new BPC-157 study, and some even claiming it “reduces inflammation by 50%” (study name is Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Peptide Therapy for Lyme Disease:

Minor strains and mild tendinitis often resolve in 4-6 weeks

A skeptical review published last year in the journal Pharmaceuticals laid out the gaps in detail, and Sikirics group had to publish a rebuttal

Injections cost more per dose because there is a charge for the medical service and the pharmaceutical-grade vitamin, but more of what you pay for is actually absorbed

Despite a near-total lack of evidence that BPC 157 is effective or even safe for use in humans, this peptide is being touted for use to repair muscle, tendon and ligament damage in athletes, for recovery from surgery, and to improve gut health, amongst other indications

The FDA raised concerns about limited human trials, inconsistent chemical information, possible immune reactions and difficulty confirming the purity of finished products